MedTrace Logo

Smartwatch ABPM vs. Conventional ABPM

NCT04553861 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2021-04-08

No results posted yet for this study

Summary

This study aims to investigate the accuracy and precision of the Samsung Smartwatch with conventional ambulatory blood pressure monitoring in healthy volunteers.

Conditions

  • Blood Pressure

Interventions

DEVICE

Ambulatory blood pressure monitoring

Every 30 minutes from 7 AM to 10 PM and every 1 hour from 10 PM to 7 AM

DEVICE

Galaxy Watch Active2

Every 1 hour by subject (on-demand) from 7 AM to 10 PM and every 5 minutes (automatic) from 10 PM to 7 AM

Sponsors & Collaborators

  • Samsung Electronics

    collaborator INDUSTRY

  • Wonju Severance Christian Hospital

    lead OTHER

Principal Investigators

  • Young Jin Youn, MD, PhD · Wonju Severance Christian Hospital

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-11-01
Primary Completion
2020-12-31
Completion
2021-03-01

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04553861 on ClinicalTrials.gov